CA2285457A1 - Method for oral delivery of proteins - Google Patents

Method for oral delivery of proteins Download PDF

Info

Publication number
CA2285457A1
CA2285457A1 CA002285457A CA2285457A CA2285457A1 CA 2285457 A1 CA2285457 A1 CA 2285457A1 CA 002285457 A CA002285457 A CA 002285457A CA 2285457 A CA2285457 A CA 2285457A CA 2285457 A1 CA2285457 A1 CA 2285457A1
Authority
CA
Canada
Prior art keywords
composition
insulin
hydrogels
maa
hydrogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002285457A
Other languages
English (en)
French (fr)
Inventor
Mariko Morishita
Tsuneji Nagai
Nicholas A. Peppas
Anthony M. Lowman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2285457A1 publication Critical patent/CA2285457A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
CA002285457A 1997-04-02 1998-04-02 Method for oral delivery of proteins Abandoned CA2285457A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4228097P 1997-04-02 1997-04-02
US60/042,280 1997-04-02
US6136797P 1997-10-08 1997-10-08
US60/061,367 1997-10-08
PCT/US1998/006563 WO1998043615A1 (en) 1997-04-02 1998-04-02 Method for oral delivery of proteins

Publications (1)

Publication Number Publication Date
CA2285457A1 true CA2285457A1 (en) 1998-10-08

Family

ID=26719055

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002285457A Abandoned CA2285457A1 (en) 1997-04-02 1998-04-02 Method for oral delivery of proteins

Country Status (14)

Country Link
EP (1) EP0975328A1 (zh)
JP (1) JP2002512607A (zh)
KR (1) KR20010005952A (zh)
CN (1) CN1259045A (zh)
AU (1) AU727053B2 (zh)
BR (1) BR9808466A (zh)
CA (1) CA2285457A1 (zh)
IL (1) IL132176A0 (zh)
NO (1) NO994757L (zh)
NZ (1) NZ500075A (zh)
PL (1) PL335974A1 (zh)
TR (1) TR199903240T2 (zh)
WO (1) WO1998043615A1 (zh)
YU (1) YU49699A (zh)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
DE10040592A1 (de) * 2000-08-15 2002-03-07 Aventis Res & Tech Gmbh & Co Formulierung zur verbesserten Aufnahme von Wirkstoffen und deren Verwendung
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
ES2300568T3 (es) 2002-03-20 2008-06-16 Mannkind Corporation Aparato de inhalacion.
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
BR122019022692B1 (pt) 2004-08-23 2023-01-10 Mannkind Corporation Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
US8110212B2 (en) 2005-04-07 2012-02-07 Drexel University Bioactive thermogelling polymer systems and methods of their use
PL1916995T5 (pl) 2005-07-29 2022-10-31 Stichting Groningen Centre For Drug Research Kontrolowany wartością ph impulsowy układ podawczy, sposoby przygotowania i zastosowanie
DK1915171T3 (da) * 2005-08-01 2013-12-09 Mannkind Corp Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler
HUE028691T2 (en) 2005-09-14 2016-12-28 Mannkind Corp A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
CN101500623B (zh) 2006-06-15 2016-08-24 微温森公司 一种由可膨胀聚合物构成的栓塞器械
CA2709379C (en) 2007-12-21 2016-08-16 Microvention, Inc. Hydrogel filaments for biomedical uses
AR072114A1 (es) 2008-06-13 2010-08-04 Mannkind Corp Un inhalador de polvo seco y sistema para suministro de farmacos
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
BRPI0914308B8 (pt) 2008-06-20 2021-06-22 Mannkind Corp sistema de inalação
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
KR101875969B1 (ko) 2009-06-12 2018-07-06 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
US9114200B2 (en) 2009-09-24 2015-08-25 Microvention, Inc. Injectable hydrogel filaments for biomedical uses
CA2777171C (en) 2009-10-26 2017-09-19 Microvention, Inc. Embolization device constructed from expansile polymer
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
RU2571331C1 (ru) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
JP6133270B2 (ja) 2011-04-01 2017-05-24 マンカインド コーポレイション 薬剤カートリッジのためのブリスター包装
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
JP6018640B2 (ja) 2011-10-24 2016-11-02 マンカインド コーポレイション 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
WO2014144895A1 (en) 2013-03-15 2014-09-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
AU2014290438B2 (en) 2013-07-18 2019-11-07 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015021044A1 (en) * 2013-08-05 2015-02-12 University Of Rochester Compositions and methods for stimuli-responsive release of a therapeutic agent
WO2015021064A1 (en) 2013-08-05 2015-02-12 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US10226533B2 (en) 2014-04-29 2019-03-12 Microvention, Inc. Polymer filaments including pharmaceutical agents and delivering same
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10265405B2 (en) 2014-11-18 2019-04-23 Board Of Regents, The University Of Texas System Polymers for delivery of factor VIII and/or factor IX
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976576A (en) * 1956-04-24 1961-03-28 Wichterle Otto Process for producing shaped articles from three-dimensional hydrophilic high polymers
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
DE1617393C2 (de) * 1966-01-06 1982-11-11 Československá akademie věd, Praha Verfahren zur Herstellung von biologisch aktive Stoffe enthaltenden hydrophilen vernetzten Copolymeren
US3607848A (en) * 1967-08-07 1971-09-21 Ceskoslovenska Akademie Ved Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters
US3885078A (en) * 1968-03-06 1975-05-20 Ceskoslovenska Akademie Ved Hydrogel laminates and method of manufacturing thereof
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
FR2601026B1 (fr) * 1986-04-15 1988-09-16 Rhone Poulenc Chimie Matiere seche hydratable en un gel aqueux contenant des particules de polymeres dispersees, procede pour sa preparation et son application en biologie

Also Published As

Publication number Publication date
TR199903240T2 (xx) 2000-05-22
AU727053B2 (en) 2000-11-30
EP0975328A1 (en) 2000-02-02
IL132176A0 (en) 2001-03-19
PL335974A1 (en) 2000-06-05
NO994757L (no) 1999-11-29
YU49699A (sh) 2002-12-10
AU6880998A (en) 1998-10-22
BR9808466A (pt) 2001-08-07
KR20010005952A (ko) 2001-01-15
JP2002512607A (ja) 2002-04-23
CN1259045A (zh) 2000-07-05
NZ500075A (en) 2001-03-30
NO994757D0 (no) 1999-09-30
WO1998043615A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
AU727053B2 (en) Method for oral delivery of proteins
Lowman et al. Oral delivery of insulin using pH‐responsive complexation gels
Foss et al. Development of acrylic-based copolymers for oral insulin delivery
Morishita et al. Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers
Nakamura et al. Oral insulin delivery using P (MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics
Jiménez-castellanos et al. Mucoadhesive drug delivery systems
Morishita et al. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption
Kim et al. Polymeric drug delivery systems
EP0245820B1 (en) Biodegradable microspheres as a carrier for macromolecules
US5160745A (en) Biodegradable microspheres as a carrier for macromolecules
Peppas et al. Hydrogels for oral delivery of therapeutic proteins
Martin et al. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels
Kamei et al. Complexation hydrogels for intestinal delivery of interferon β and calcitonin
Ramkissoon-Ganorkar et al. Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight
EP0434438B1 (en) Hydrolytically degradable hydrophilic gels and the method for preparation thereof
Kumar et al. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery
CA2018471A1 (en) Mucoadhesive hydrogels delivery system
WO1995003035A1 (en) Polymerized liposomes with enhanced stability for oral delivery
WO1998022097A2 (en) Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
WO2020072729A1 (en) Oral dosage form with surface delivery of active agent
Goto et al. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats
WO2008055254A2 (en) Formulations and methods for oral delivery of proteins
Smart Some formulation factors influencing the rate of drug release from bioadhesiw matrices
AU2002256333B2 (en) A release pharmaceutical construct for gastric retention
CZ349499A3 (cs) Farmaceutický přípravek určený pro orální podávání, způsob jeho použití a výroby

Legal Events

Date Code Title Description
FZDE Discontinued